South San Francisco, California Saturday, July 19, 2025, 14:00 Hrs [IST] ...

Prima Mente launches Pleiades, a human epigenome foundation model with applications for Alzheimer’s disease: London Saturday, July 19, 2025, 18:00 Hrs [IST] San Francisco and Lo ...

Nanochon gets Health Canada approval for first in human investigation to assess safety and performance of its Chondrograft system: Washington Saturday, July 19, 2025, 16:00 Hrs [I ...

Synendos Therapeutics appoints Dr. George Garibaldi as CMO to enhance phase 2 clinical development of its lead drug asset SYT-510: Basel, Switzerland Saturday, July 19, 2025, 15:3 ...

US FDA accepts resubmitted NDA of Aldeyra Therapeutics for review of topical ocular reproxalap to treat dry eye disease: Lexington, Massachusetts Saturday, July 19, 2025, 13:00 Hr ...

Rocket Pharma receives US FDA regenerative medicine advanced therapy designation for RP-A601 gene therapy: Cranbury, New Jersey Saturday, July 19, 2025, 15:00 Hrs [IST] Rocket Pha ...

Repare Therapeutics signs exclusive global licensing agreement with Debiopharm International for lunresertib: Cambridge, Massachusetts Saturday, July 19, 2025, 17:00 Hrs [IST] Rep ...

Genascence’s GNSC-001 for knee osteoarthritis receives US FDA regenerative medicine advanced therapy designation: Palo Alto, California Saturday, July 19, 2025, 16:30 Hrs [IST] ...

Seongnam, South Korea Saturday, July 19, 2025, 12:00 Hrs [IST] ...

PCI asks State Councils to submit consolidated data of pharmacists for HPR: Our Bureau, New Delhi Saturday, July 19, 2025, 08 ...

Raritan, New Jersey Friday, July 18, 2025, 15:00 Hrs [IST] ...

Miltenyi Biotec and THSTI FIVE partner to launch India’s first hands-on CAR-T cell and gene therapy training curriculum: Our ...